DE69400887D1 - Sulphonamid-Derivate - Google Patents
Sulphonamid-DerivateInfo
- Publication number
- DE69400887D1 DE69400887D1 DE69400887T DE69400887T DE69400887D1 DE 69400887 D1 DE69400887 D1 DE 69400887D1 DE 69400887 T DE69400887 T DE 69400887T DE 69400887 T DE69400887 T DE 69400887T DE 69400887 D1 DE69400887 D1 DE 69400887D1
- Authority
- DE
- Germany
- Prior art keywords
- cathepsin
- sulphonamide derivatives
- amyotrophia
- calpain
- hypercalcemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10278293 | 1993-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69400887D1 true DE69400887D1 (de) | 1996-12-19 |
DE69400887T2 DE69400887T2 (de) | 1997-05-22 |
Family
ID=14336717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69400887T Expired - Fee Related DE69400887T2 (de) | 1993-04-28 | 1994-04-21 | Sulphonamid-Derivate |
Country Status (10)
Country | Link |
---|---|
US (1) | US5506243A (de) |
EP (1) | EP0623627B1 (de) |
JP (1) | JP3599287B2 (de) |
AT (1) | ATE145214T1 (de) |
CA (1) | CA2121523C (de) |
DE (1) | DE69400887T2 (de) |
DK (1) | DK0623627T3 (de) |
ES (1) | ES2096370T3 (de) |
GR (1) | GR3022524T3 (de) |
TW (1) | TW261608B (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
DE69625622T2 (de) * | 1995-10-25 | 2003-08-14 | Senju Pharma Co | Angiogenese Inhibitoren |
EP0928786B1 (de) * | 1995-10-25 | 2003-01-02 | Senju Pharmaceutical Co., Ltd. | Angiogenese Inhibitoren |
US6214800B1 (en) | 1995-10-25 | 2001-04-10 | Senju Pharmaceutical Co., Ltd. | Angiogenesis inhibitor |
EP0910564B1 (de) * | 1995-11-28 | 2007-10-31 | Cephalon, Inc. | Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer |
US6653331B2 (en) * | 1996-07-03 | 2003-11-25 | Pharmacia & Upjohn Company | Targeted drug delivery using sulfonamide derivatives |
AU3805497A (en) * | 1996-07-19 | 1998-02-10 | Neurotrauma Therapeutics, Inc. | Calpain inhibitors for the treatment of traumatic brain injury |
WO1998003191A1 (en) * | 1996-07-19 | 1998-01-29 | Neurotrauma Therapeutics, Inc. | Calpain inhibitors for the treatment of cerebral ischemia, spinal cord injury or stroke |
WO1998018485A1 (en) | 1996-10-31 | 1998-05-07 | Alcon Laboratories, Inc. | The use of calpain inhibitors to treat ocular neural pathology |
NZ335480A (en) | 1996-12-31 | 2001-04-27 | Guilford Pharm Inc | Neurotrophic low molecular weight N-linked sulfonamides of heterocyclic thioesters and their use as inhibitors of immunophilin proteins |
US5874449A (en) * | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
AR013079A1 (es) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
AU2745599A (en) * | 1998-03-05 | 1999-09-20 | Senju Pharmaceutical Co., Ltd. | Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
CN1295561A (zh) | 1998-06-03 | 2001-05-16 | Gpinil控股公司 | N-杂环羧酸或羧酸等排物的n-结合氨磺酰 |
US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
WO2000021550A2 (en) * | 1998-10-13 | 2000-04-20 | President And Fellows Of Harvard College | Methods and compositions for treating neurodegenerative diseases |
US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
EP1244670B1 (de) | 1999-12-21 | 2006-03-08 | MGI GP, Inc. | Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung |
KR20020067702A (ko) * | 2000-01-26 | 2002-08-23 | 오노 야꾸힝 고교 가부시키가이샤 | 질소 함유 5원환 화합물 및 이러한 화합물을 유효성분으로서 함유하는 약제 |
US6803233B2 (en) * | 2000-07-31 | 2004-10-12 | The Regents Of The University Of California | Model for Alzheimer's disease and other neurodegenerative diseases |
AU2001292287A1 (en) * | 2000-10-26 | 2002-05-06 | Senju Pharmaceutical Co. Ltd. | Drug composition comprising dipeptydyl aldehyde derivative |
ATE330950T1 (de) * | 2000-12-13 | 2006-07-15 | Wyeth Corp | Heterocyclische sulfonamide als inhibitoren der beta-amyloid-produktion |
JP4549851B2 (ja) * | 2002-07-22 | 2010-09-22 | 千寿製薬株式会社 | 新規α−ケトアミド誘導体およびその用途 |
US7662849B2 (en) | 2003-06-04 | 2010-02-16 | Virobay, Inc. | Amidino compounds as cysteine protease inhibitors |
SG146658A1 (en) | 2003-09-18 | 2008-10-30 | Schering Ag | Haloalkyl containing compounds as cysteine protease inhibitors |
US8163735B2 (en) | 2004-12-02 | 2012-04-24 | Virobay, Inc. | Sulfonamide compounds as cysteine protease inhibitors |
EA017874B1 (ru) | 2005-03-21 | 2013-03-29 | Вайробей, Инк. | Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз |
JP5215167B2 (ja) | 2005-03-22 | 2013-06-19 | ビロベイ,インコーポレイティド | システインプロテアーゼ阻害剤としてのスルホニル基含有化合物 |
WO2008045017A2 (en) * | 2005-06-22 | 2008-04-17 | Diamond Scott L | Sars and ebola inhibitors and use thereof, and methods for their discovery |
US7893112B2 (en) | 2006-10-04 | 2011-02-22 | Virobay, Inc. | Di-fluoro containing compounds as cysteine protease inhibitors |
EP2079683B1 (de) | 2006-10-04 | 2015-01-21 | Virobay, Inc. | Difluorhaltige verbindungen als cysteinproteasehemmer |
US8324417B2 (en) | 2009-08-19 | 2012-12-04 | Virobay, Inc. | Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof |
EP3755352A4 (de) * | 2018-02-20 | 2021-12-22 | Edgewise Therapeutics, Inc. | Verfahren und zusammensetzungen zur behandlung von bewegungserkrankungen |
JP7355777B2 (ja) | 2021-03-31 | 2023-10-03 | 本田技研工業株式会社 | 切削工具 |
WO2024018245A1 (en) | 2022-07-22 | 2024-01-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of calpain inhibitors for the treatment of the diabetic kidney disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5754157A (en) * | 1980-09-19 | 1982-03-31 | Nippon Kayaku Co Ltd | L-argininal derivative and its preparation |
JP2701932B2 (ja) * | 1989-04-10 | 1998-01-21 | サントリー株式会社 | タンパク質分解酵素阻害剤 |
EP0504938A3 (en) * | 1991-03-22 | 1993-04-14 | Suntory Limited | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
-
1994
- 1994-04-05 JP JP6724294A patent/JP3599287B2/ja not_active Expired - Fee Related
- 1994-04-08 TW TW083103077A patent/TW261608B/zh active
- 1994-04-18 CA CA002121523A patent/CA2121523C/en not_active Expired - Fee Related
- 1994-04-21 AT AT94106225T patent/ATE145214T1/de not_active IP Right Cessation
- 1994-04-21 DE DE69400887T patent/DE69400887T2/de not_active Expired - Fee Related
- 1994-04-21 DK DK94106225.9T patent/DK0623627T3/da active
- 1994-04-21 ES ES94106225T patent/ES2096370T3/es not_active Expired - Lifetime
- 1994-04-21 EP EP94106225A patent/EP0623627B1/de not_active Expired - Lifetime
- 1994-04-28 US US08/233,963 patent/US5506243A/en not_active Expired - Fee Related
-
1997
- 1997-02-12 GR GR970400212T patent/GR3022524T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69400887T2 (de) | 1997-05-22 |
US5506243A (en) | 1996-04-09 |
CA2121523A1 (en) | 1994-10-29 |
DK0623627T3 (da) | 1997-04-28 |
GR3022524T3 (en) | 1997-05-31 |
JP3599287B2 (ja) | 2004-12-08 |
EP0623627B1 (de) | 1996-11-13 |
JPH0748340A (ja) | 1995-02-21 |
ATE145214T1 (de) | 1996-11-15 |
CA2121523C (en) | 2006-06-20 |
TW261608B (de) | 1995-11-01 |
ES2096370T3 (es) | 1997-03-01 |
EP0623627A1 (de) | 1994-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE145214T1 (de) | Sulphonamid-derivate | |
ES2117088T3 (es) | Derivados de aminocetonas. | |
CA2217737A1 (en) | Thf-containing sulfonamide inhibitors of aspartyl protease | |
EP0885887A3 (de) | Sulfonamide Inhibitore von HIV-Aspartyl Protease | |
AP9600827A0 (en) | Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease. | |
EP0739338A4 (de) | Neue sterin-protease inhibitoren: isothiazolidin-3-on-1,1-dioxid und 3-oxo-1,2,5-thiadiazolidin 1,1-dioxid | |
DE60214392D1 (de) | 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen | |
DE69624346T2 (de) | Verbindung der struktur aminosäure-hydroxyethylamino-sulfonamide als inhibitoren der retroviralen protease | |
HUP0203130A2 (hu) | Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2-(hidroxi-propil)}-karbamát mint retrovírus-proteáz-gátló | |
NO20033918L (no) | Ny anvendelse av peptidklasse av forbindelser for behandling av allodyni eller andre typer av kronisk smerte eller fantomsmerte | |
NO952207D0 (no) | Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel | |
DE60132177D1 (en) | Aminosäure-derivate als hiv aspartyl-protease-inhibitoren | |
DZ3008A1 (fr) | Inhibiteurs de l'aspartyle protéase. | |
NO974322L (no) | DNA som koder for human papillomvirus type 18 | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
NO942983D0 (no) | Farmasöytiske sammensetninger | |
WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
DK0642574T3 (da) | Detergentsammensætninger | |
EA199900683A1 (ru) | Тетрагидрофураны | |
ATE359218T1 (de) | Verriegelungsmechanismus für einen behälter | |
MX9708055A (es) | Inhibidores de aspartil proteasa consistentes en sulfonamida que contiene heterociclo oxigenado. | |
MX9708057A (es) | Sulfonamidas que contienen thf inhibidoras de la aspartilproteasa. | |
ES555466A0 (es) | Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |